Tag Archives: DCTH

Best Stocks To Own For 2018

You’ve likely seen the TV commercials for reverse mortgages, with the late Fred Thompson, Henry Winkler and, lately, Tom Selleck. But just between us: Do you really understand how a reverse mortgage works? If not, don’t feel bad — in a March 2017 National Council on Aging survey, 66% of older homeowners said they’d need to do more research to understand a reverse mortgage line of credit.

Credit: Shutterstock

But I can offer some assistance to help explain how reverse mortgages work and cautions about them, based on a reverse mortgage webinar I just hosted.

The one-hour Q & A With Reverse Mortgage Experts — which you can download here — featured answers to questions from Next Avenue readers and others. The webinar was one of six from the National Reverse Mortgage Lenders Association (NRMLA) as part of Reverse Mortgage Education Week. The four webinar experts were: Peter Bell, president and CEO of NRMLA; Lance Canada, a Certified Reverse Mortgage Professional with First Bank; Tera Guy, vice president for operations at James B Nutter and Company, a reverse mortgage lender; and Phil Stevenson, owner and principal of the reverse mortgage lender PS Financial Services and a Certified Reverse Mortgage Professional.

Best Stocks To Own For 2018: Fidelity Southern Corporation(LION)

Advisors’ Opinion:

  • [By Lisa Levin]

    Here is the list of stocks going ex-dividend on Monday.

    AptarGroup, Inc. (NYSE: ATR) – $0.3200 dividend, 1.6780 percent yield. AptarGroup reported weaker-than-expected Q3 results on Thursday.
    Fidelity Southern Corporation (NASDAQ: LION) – $0.1200 dividend, 2.6359 percent yield. The company, based in Atlanta, Georgia, provides financial products and services for customers.
    Apple Hospitality REIT Inc (NYSE: APLE) – $0.1000 dividend, 6.5826 percent yield. Apple Hospitality REIT, based in Richmond, Virginia, operates as a subsidiary of Apple REIT Companies.
    Targa Resources Corp (NYSE: TRGP) – $0.9100 dividend, 7.7299 percent yield. The Houston, Texas-based company provides midstream natura

Best Stocks To Own For 2018: Delcath Systems Inc.(DCTH)

Advisors’ Opinion:

  • [By Money Morning News Team]

    If you’re looking for proof of just how explosively profitable penny stocks are, Delcath Systems Inc. (Nasdaq: DCTH) is a perfect piece of evidence. This company saw its stock price surge from $0.02 on June 1 to $0.19 on June 26. That marked a stunning 850% gain, which happened after the company announced phase 2 trial data for its cancer drug Melphalan would be released.

  • [By Paul Ausick]

    Delcath Systems Inc. (NASDAQ: DCTH) dropped nearly 44% Friday to post a new 52-week low of $0.46 after closing Thursday at $0.82. The 52-week high is $8.80. Volume of around 4.5 million was more than 20 times the daily average of around 280,000 shares traded. The company had no specific news.

Best Stocks To Own For 2018: Regeneron Pharmaceuticals, Inc.(REGN)

Advisors’ Opinion:

  • [By Johanna Bennett]

    Shares of biotechnology giant Regeneron Pharmaceuticals (REGN) have climbed more than 4% today after Piper Jaffray analyst Ed Tenthoff upgraded the stock from a neutral to an overweight, with a $446 price target.

    The upgrade comes just a few days after the drug maker released soft guidance for 2017 and forecasts called for slowing sales of the eye drug Eylea.

    But Piper Jaffrays Tenthoff argues that anticipated approvals and deep pipeline should drive long-term value. Of particular importance: the atopic dermatitis drug Dupixent (dupilumab).

    We are confident in FDA approval of Dupixent (dupilumab) in moderate-to-severe atopic dermatitis by the March 29th PDUFA date and in Europe in late 2017. The Phase III LIBERTY ASTHMA QUEST study has fully enrolled 1,858 persistent asthma patients to 200mg and 300mg subcu Dupixent q2W. We look for data this year to enable an sBLA submission by YE:17. Regeneron is conducting two Phase III trials in nasal polyps and will initiate Phase III pediatric atopic dermatitis and asthma trials. The company will report data from a Phase II eosinophilic esophagitis study in 1H:17 and begin a Phase II food allergy study in 2H:17. The FDA has deemed Sanofi’s Le Trait facility “acceptable”. As a result, we anticipate the partners will refile on Kevzara (sarilumab) and could gain approval in 2Q:17. These two launches should turn Regeneron’s antibody alliance with Sanofi profitable.

    Todays news is the latest development in what has been a volatile time the drug maker. The shares have fallen sharply over the during the last three months, the result of a patent suit with Amgen (AMGN) over its anti-cholesterol drug Praluent, which a judge had set it wouldnt be able to sell in the U.S. , But last week, a judge granted a stay that would allow Regeneron to sell Praluent. It also fueled a pop in its shares.

    The next day, however, Regeneron reported earnings, and while profits o

  • [By WWW.THESTREET.COM]

    That’s why Cramer said he’ll be listening for news coming from Celgene (CEL) , Amgen (AMGN) , Allergan (AGN) , an Action Alerts PLUS holding, and Regenron (REGN) , all of which are set to present. Of the four, Cramer said he’s sticking with Allergan and Amgen.

  • [By Ben Levisohn]

    Regeneron Pharmaceuticals (REGN) tumbled to the bottom of the S&P 500 today after a judge said the company could be forced to stop selling an anti-cholesterol drug due to violating an Amgen (AMGN) patent.

    Agence France-Presse/Getty Images

    Regeneron Pharmaceuticalsdropped 5.8% to $358.68 today, while the S&P 500 rose 0.4% to 2,276.98.

    Chardan’sGbola Amusa takes a victory lap:

    Yesterday, after markets closed, it was announced that US Federal District Court Judge Sue Robinson ruled to issue a permanent injunction against Praluent, the PCSK9 mAb for hypercholesterolemia from partners Regeneron and Sanofi, due to infringement of patents from Amgen. The court has imposed a 30-day suspension (stay) on the injunction to allow for settlement or appeal of the District Court decision. Sanofi and Regeneron have announced their intent to appeal the ruling to the US Court of Appeals for the Federal Circuit (CAFC). The injunction decision is consistent with our counter-consensus published views communicated on 25 January 2016 (“Downgrade to Sell on evidence of likely infringement of Amgen’s PCSK9 patents”) and subsequently. Based on consultation with expert legal counsel, we now put >75% probability Amgen will prevail on appeal and/or Praluent is ultimately removed from the US market, and/or Amgen achieves a settlement substantially in its favor. We currently model $3.3 bn in non-risk-adjusted 2022E US revenues for Praluent, while consensus models $1.2 bn in 2022E US revenues. We reiterate our view from 25 January 2016 to preferentially own Amgen, The Medicines Company (MDCO) (Buy), and Alnylam (ALNY) (Buy) over Regeneron for exposure to PCSK9 inhibitor market dynamics as outcomes trials approach.

    While the loss is bad news for Regeneron, Barron’s Johanna Bennettargues that it could herald a comeback for Amgen.

    Regeneron’s market capitalization fell to $38.5 billion today from $40.2 bil

  • [By ]

    Celgene (CELG) : “I’d rather buy Amgen (AMGN) or Regeneron Pharmaceuticals (REGN) . I think Celgene overpaid for that acquisition a few years ago.”

  • [By Chris Lange]

    Shares of Amgen Inc. (NASDAQ: AMGN) saw a handy gain to close out the week after the company won a Delaware court ruling that blocked Sanofi (NYSE: SNY) and Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) from selling their cholesterol-lowering drug in the United States. Essentially the court found that the drug Praluent actually infringed upon Amgens patents for its rival treatment Repatha.

Best Stocks To Own For 2018: Viva Entertainment Group (OTTV)

Advisors’ Opinion:

  • [By Matthew Briar]

    Everything that Viva Entertainment Group Inc (OTCMKTS:OTTV) was offering via its app as of yesterday just got expanded today. Per this morning’s press release, all the digital content from FlixFling is going to be available on the Viva over-the-top television (and music) streaming platform.

    The product is called Viva Middleware. The software/platform allows anyone to get into the over-the-top television business like Netflix and Hulu already are. Telecom service providers, media websites, universities, and pretty much anyone else can custom-build their own IPTV service, and collect subscription fees and/or ad revenue for doing so. Viva does all the back-end work, while the seller collects the customers.

    The trick is simply filling the pipeline with content, and at the same time, convincing customers that there’s enough quality content at the source to become a paying subscriber. And in this case, the fact that the app works on any operating system or any device is a key selling feature.

    Viva Entertainment Group has already been curating content for a while now, and has a nice library including a huge number of radio stations. That content took a huge leap forward today, however, with FlixFling being added to the mix.

    If it rings a bell for OTTV shareholders, it should. FlixFling is streaming media company started by Thomas Ashley, who just so happened to join the OTTV Board of Directors last week.

    FlixFling is an online video-on-demand content provider specializing in new, previously released and classic movies from most major studios. Customers can watch thousands of movie selections on an easy, flexible interface from your favorite devices or connected TV. FlixFling brings a new and exciting movie content viewing experience to customers who can’t find what they want through other online video rental sites; FlixFling has access to new releases quicker than Hulu or Netflix, Inc. (NASDAQ:NFLX).

    It’s a real coup for

  • [By Matthew Briar]

    If one wants to know why cord-cutting is a full-blown movement, one only has to look at Viva Entertainment Group Inc (OTCMKTS:OTTV). And, in light of today’s news, the movement is only going to accelerate as we move deeper into 2017. Fans of small cap stocks and technological paradigm shifts may want to put OTTV on their radar, if not in their portfolio.

    The product is called Viva Middleware, which in simplest terms is a turn-key technology that allows anyone to get into the OTT (over the top television) business with their own customized over-the-top television service. Live broadcasts, on-demand, music channels and original programming are all possible. This means they can customize the product locally or regionally, or thematically, like an all-sports or an all sci-fi venue. Indeed, the company has already announced a joint venture with Oi2 Media – the United States’ biggest distributor of Latino-centric digital content – to create an OTT product catering to a specific segment of the nation’s demographic. The possibilities are endless though… including such a service from Viva Entertainment Group itself.

    That is, in fact, what’s been happening. Over the course of the past several months the company has been in discussions with several digital video content providers and venues, adding their content to Viva’s platform. Last month it added FlixFling content to its already-extensive library. Today, it announced it would be piping in content from TikiLIVE, which offers online access to an impressive array of television programs that many consumers presumed were only available with a cable subscription.

    Viva Entertainment Group CEO Johnny Falcones explained:

  • [By Matthew Briar]

    The phrase “over the top television” or “OTT” for short, aren’t exactly new terms. The phrase/abbreviation was coined shortly after Netflix, Inc. (NASDAQ:NFLX) became a viable alternative to traditional cable television subscriptions a little less than a decade ago. The over-the-top battle didn’t get heated, though, until the past few months. But, now that some more gladiators are in the arena, sparks are starting to fly.

    They’re still flying too, and should do so for a while if a small startup called Viva Entertainment Group Inc (OTCMKTS:OTTV) has anything to do with it it. See, while Netflix, Hulu — jointly owned by Time Warner, Walt Disney Co (NYSE:DIS) and Twenty-First Century Fox Inc (NASDAQ:FOXA) — and a whole slew of other new players in this market may want to take notice of this up-and-comer. At the same time, investors may want to take a step back and look at where the real money in the OTT business is going to be made over the course of the next several years. OTTV plays a prominent role in that picture.

    Contrary to popular belief, Netflix isn’t the dominant name it used to be in the Internet-delivered television industry. Yes, it was the first on the scene as such was was able to carve out the biggest piece of the market. It’s largely become a commoditized business in the meantime though.

    For example, outside of Hulu and Netflix, CBS Corporation (NYSE:CBS) has jumped into the fray with a service called CBS All Access. The product allows subscribers -for a nominal monthly fee – access a variety of CBS programming via the Internet. HBO, from Time Warner Inc (NYSE:TWX), has found some measurable success with its subscription-based Internet television service called HBO Go.

    Sling TV, from DISH Network Corp (NASDAQ:DISH), is another one of the alternatives to the alternative that’s truly made a dent in the over the top market…. by aggregating a variety of television channels into an entire package and then selling that p

  • [By Bryan Murphy]

    Don’t look for any news to explain the big 73% surge Viva Entertainment Group Inc (OTCMKTS:OTTV) dished out on Monday – you won’t find it, because there wasn’t any. Rather, OTTV shares popped all on their own.

    The knee-jerk reaction may be to presume OTTV stock is destined to roll back just as quickly as the rally materialized. And, that may well be what’s in the cards. Before looking past Viva Entertainment Group as an investment opportunity that’s dead money until further notice though, Monday’s mostly-overlooked action may be a huge bullish clue.

    For the unfamiliar, the company’s product is called Viva Middleware. The software/platform allows anyone to get into the over-the-top television business like Netflix and Hulu already are. Telecom service providers, media websites, universities, and pretty much anyone else can custom-build their own IPTV service, and collect subscription fees and/or ad revenue for doing so. Viva does all the back-end work, while the seller collects the customers.

    The trick is simply filling the pipeline with content, and at the same time, convincing customers that there’s enough quality content at the source to become a paying subscriber. And in this case, the fact that the app works on any operating system or any device is a key selling feature.

    Viva Entertainment Group has already been curating content for a while now, and has a nice library including a huge number of radio stations.

    The stock, though, hasn’t exactly been rewarding even though the company’s back-story has been compelling. That paradigm shift may have changed on Monday.

    Take a look. Out of nowhere, a ton of volume materialized on Monday… most of it bullish. There’s still a ton of ground left to make up, to be sure, but this is interesting. There was far more buying than selling on Monday, on HUGE volume. Why the sudden interest in buying a beaten-down OTTV? That’s the point. For one reason or another, the mood/rheto

  • [By James E. Brumley]

    It’s almost here. Viva Entertainment Group Inc (OTCMKTS:OTTV) is about to unveil its long-awaited over-the-top (OTT) television platform that’s poised to disrupt the entire television industry even more than it’s already been up-ended.

    And it’s going to debut that technology in style. On December 13th, at the Riviera Hotel in South Beach Miami, OTTV will be hosting a launch party to debut its Viva OTT platform. Not only will the event give guests a chance to see and use the over-the-top television platform, they’ll be dazzled by performances by Soleil J and Jorge Moreno.

    The product is called Viva Middleware, which in simplest terms is a turn-key technology that allows anyone to get into the OTT business with their own customized over-the-top television service. Live broadcasts, on-demand, music channels and original programming are all possible. This means they can customize the product locally or regionally, or thematically, like an all-sports or an all sci-fi venue. The possibilities are endless, which is in stark contrast to Netflix’s “what you get is what you get” approach.

    And Viva Entertainment Group already has clients. In August the company announced it was entering a joint venture with Oi2 Media to create an OTT product catering to a specific segment of the nation’s demographic.

    Oi2 Media is the United States’ biggest distributor of Latino-centric digital content, offering both music and television. It’s not just a Netflix-like service Oi2 and Viva will be providing, however. The Viva platform can serve as a robust alternative to cable television service, much of which is delivered in English and is therefore unusable to much of the Latino/Hispanic community.

    It’s no small market either. Portada recently estimated that the Hispanic online-video ad market alone would be worth $425 million by 2020, pointing to the greater segmentation of the video market now that advancements in technology have made it possible. A

Top 10 Blue Chip Stocks To Invest In 2019

If small-company stocks offer the chance to get into businesses on the ground floor, and big blue chips offer world-beating stability, what do shares of midsize companies bring to the table? Historically, superior returns. Since 1980, the Russell Midcap index, which tracks U.S. stocks with $934 million to $34 billion in market capitalization (stock price times shares outstanding), returned 12.9% per year, on averageahead of the large-cap Standard & Poors 500-stock index (11.7%) and the small-cap Russell 2000 index (11%).

See Also: Mid-Cap Stocks Are the Market’s Sweet Spot

Patrick Dunkerley, who comanages the Scout Mid Cap Fund (UMBMX), describes mid caps as a market sweet spot, offering more stability than small companies (thanks to, among other things, more-seasoned executives) and better growth potential than large firms. The fund, which holds 142 stocks, aims to eclipse the long-term performance of the Russell Midcap index.

Top 10 Blue Chip Stocks To Invest In 2019: National Fuel Gas Company(NFG)

Advisors’ Opinion:

  • [By Lee Jackson]

    These companies also reported insider selling last week: National Fuel Gas Co. (NYSE: NFG), Prologis Inc. (NYSE: PLD), Realty Income Corp. (NYSE: O), Ulta Beauty Inc. (NASDAQ: ULTA) and Versartis Inc. (NASDAQ: VSAR).

Top 10 Blue Chip Stocks To Invest In 2019: Ono Pharmaceutical Co., Ltd. (OPHLF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    Merck could achieve a consistent advantage versus BMS in treatment of 1L NSCLC. There is a precise crossroad that will determine the future of these two companies in this field: the question of whether or not Keytruda will be approved in May. Both the market and investors believe that it will indeed gain approval and BMS’s stock is already paying for that. In the short term, the repercussions will be the contractions in the sales of Opdivo in 2L and a bigger obstacle for Opdivo+Yervoy in 1L. But the BMS’s combo can catch up, thanks to a bigger efficacy, as I will explain in a future article. Meanwhile, a recent trial established that Merck has to pay BMS $625M plus royalties, as it infringed BMS’s intellectual property related to the use of anti-PD1 antibodies. The royalties will be 6.5% for sales between January 2017 and the end of 2023, followed by a 2.5% rate for the period from January 2024 to the end of 2026. Bristol-Myers Squibb will share the money by giving a quarter of the amount to the Japanese Ono Pharmaceutical (OTC:OPHLF), the company which had discovered Opdivo.

Top 10 Blue Chip Stocks To Invest In 2019: PIMCO 25+ Year Zero Coupon US Trs ETF (ZROZ)

Advisors’ Opinion:

  • [By Todd Shriber, ETF Professor]

    Investors with a taste more rate-sensitive bond ETF may want to consider the PIMCO 25 Yr Zro Cupn US Ty Inx Fd ETF (NYSE: ZROZ) and the Vanguard Extended Duration ETF (NYSE: EDV).

Top 10 Blue Chip Stocks To Invest In 2019: Pingtan Marine Enterprise Ltd.(PME)

Advisors’ Opinion:

  • [By Rich Smith]

    Shares of Chinese fishing company Pingtan Marine Enterprise (NASDAQ:PME) collapsed on Wednesday, closing the day down more than 28.2%.

    So what

    The selling appears to have been initiated in response to an incendiary reportpublished earlier today by short-seller “Aurelius Value.” Among other things, this report alleged that Pingtan:

  • [By Lisa Levin] Related HTGM 20 Biggest Mid-Day Losers For Thursday 25 Stocks Moving In Thursday's Pre-Market Session HTG Molecular Diagnostics Obtains CE Mark for its HTG EdgeSeq ALKPlus Assay EU (GuruFocus)
    Related SSH 15 Biggest Mid-Day Gainers For Wednesday 12 Biggest Mid-Day Losers For Tuesday Healthcare – Top 5 Gainers / Losers as of 11:00 am (Seeking Alpha) Gainers
    HTG Molecular Diagnostics Inc (NASDAQ: HTGM) rose 63.6 percent to $3.50 in pre-market trading after the company disclosed that it has obtained CE marking in the EU for HTG EdgeSeq ALKPlus Assay.
    Sunshine Heart Inc (NASDAQ: SSH) rose 20.3 percent to $2.61 in pre-market trading after the company issued a business update regarding execution of its strategic growth plan.
    bebe stores, inc. (NASDAQ: BEBE) shares rose 11.1 percent to $4.29 in pre-market trading after the company disclosed that it is exploring strategic alternatives.
    Cancer Genetics Inc (NASDAQ: CGIX) rose 10.3 percent to $3.20 in pre-market trading after the company posted a narrower-than-expected quarterly loss.
    Five Below Inc (NASDAQ: FIVE) rose 8.8 percent to $41.50 in pre-market trading after the company reported better-than-expected earnings for its fourth quarter.
    FireEye Inc (NASDAQ: FEYE) rose 8 percent to $12.40 in pre-market trading. Goldman Sachs upgraded FireEye from Sell to Buy.
    PVH Corp (NYSE: PVH) shares rose 7.4 percent to $97.60 in pre-market trading after the company posted upbeat earnings for its fourth quarter and issued a strong earnings forecast.
    Bitauto Hldg Ltd (ADR) (NASDAQ: BITA) shares rose 7 percent to $26.00 in pre-market trading after dropping 1.30 percent on Wednesday.
    Pingtan Marine Enterprise Ltd (NASDAQ: PME) rose 6.6 percent to $4.50 in pre-market trading after gaining 0.48 pe
  • [By Rich Smith]

    Shares of Chinese fishing company Pingtan Marine Enterprise (NASDAQ:PME) collapsed on Wednesday, closing the day down more than 28.2%. On Thursday, they fell a further 11.9% before recovering to close down only 3.4%.

Top 10 Blue Chip Stocks To Invest In 2019: Iridium Communications Inc(IRDM)

Advisors’ Opinion:

  • [By Jim Robertson]

    Trump’s proposal to spin off air traffic control from the Federal Aviation Administration (FAA) bodes well for small cap satellite stock Iridium Communications (NASDAQ: IRDM), but theres a bigger opportunity for the Company in theInternet of Things (IoT) space. Technology company Harris Corporation (NYSE: HRS) is already a leading candidate to supply the FAA with real-time aircraft tracking data in partnership with Iridium Communications with the latter having a joint venture that has partnered with air traffic control authorities in Canada, Italy, Ireland and Denmark to provide air traffic surveillance (in cooperation with Harris).

  • [By Peter Graham]

    Small cap satellite stock Iridium Communications (NASDAQ: IRDM) reportedQ2 2017 earnings before the market opened on Thursday with results beating expectations. Total revenueincreased 2% to $111.6 million which consisted of $86.6 million of service revenue and $25.0 million of revenue related to equipment sales and engineering and support projects.Service revenue, which represents primarily recurring revenue from Iridium’s growing subscriber base, grew 4% and was 78% of total revenue. The Company ended the quarter with 913,000 total billable subscribers, which compares to 823,000 for the year-ago period and is up from 869,000 for the quarter ended March 31, 2017.Total billable subscribers grew 11% year-over-year, driven by growth in M2M and government customers. Net income was $24.8 million versus $26.9 million for the second quarter of 2016. The CEO commented:

Top 10 Blue Chip Stocks To Invest In 2019: Senior Housing Properties Trust(SNH)

Advisors’ Opinion:

  • [By Matthew Frankel]

    Healthcare real estate is just as defensive of an investment as net-lease retail, and has even more growth potential in the years ahead. One beaten-down healthcare REIT that I have my eye on in 2017 is Senior Housing Properties Trust (NASDAQ:SNH).

Top 10 Blue Chip Stocks To Invest In 2019: Newcastle Investment Corporation(NCT)

Advisors’ Opinion:

  • [By Lee Jackson]

    Newcastle Investment Corp. (NYSE: NCT) also had a director buying shares this past week. Wesley Edens picked up1 million shares of the stock at a price of $4.37. The total for the trade was posted at $4,370,000. The consensus price target for the stock is $4.50.The company invests in and manages real estate related and other investments. Its stock ended the weekat $4.31.

  • [By Jim Robertson]

    Today, our Under the Radar Moversnewsletter suggested shortingsmall cap debt and golf course REITNewcastle Investment Corp (NYSE: NCT):

    this isn’t apt to become a huge winner, but it’s a high-odds winner.

Top 10 Blue Chip Stocks To Invest In 2019: Delcath Systems Inc.(DCTH)

Advisors’ Opinion:

  • [By Money Morning News Team]

    If you’re looking for proof of just how explosively profitable penny stocks are, Delcath Systems Inc. (Nasdaq: DCTH) is a perfect piece of evidence. This company saw its stock price surge from $0.02 on June 1 to $0.19 on June 26. That marked a stunning 850% gain, which happened after the company announced phase 2 trial data for its cancer drug Melphalan would be released.

  • [By Paul Ausick]

    Delcath Systems Inc. (NASDAQ: DCTH) dropped nearly 44% Friday to post a new 52-week low of $0.46 after closing Thursday at $0.82. The 52-week high is $8.80. Volume of around 4.5 million was more than 20 times the daily average of around 280,000 shares traded. The company had no specific news.

Top 10 Blue Chip Stocks To Invest In 2019: AFC Enterprises Inc.(AFCE)

Advisors’ Opinion:

  • [By AnnaLisa Kraft]

    AFC Enterprises (NASDAQ: AFCE  ) , which owns the Popeye’s Louisiana Kitchen quick- serve chain, once an undiscovered gem, has now soared 66% over the last year.

Top 10 Blue Chip Stocks To Invest In 2019: RAIT Financial Trust(RAS)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of RAIT Financial Trust (NYSE: RAS) were down 9 percent to $1.09. FBR Capital downgraded RAIT Financial Trust from Buy to Neutral.

    Rave Restaurant Group Inc (NASDAQ: RAVE) was down, falling around 18 percent to $1.65. RAVE Restaurant reported a $5 million equity rights offering.